Efficacy and safety of corticosteroids in cardiac arrest: a systematic review, meta-analysis and trial sequential analysis of randomized control trials

• Published in: Critical care (London, England) Vol. 27; no. 1; p. 12
• Main Authors: Penn, Jeremy, Douglas, Will, Curran, Jeffrey, Chaudhuri, Dipayan, Dionne, Joanna C, Fernando, Shannon M, Granton, David, Mathew, Rebecca, Rochwerg, Bram
• Format: Journal Article
• Language: English
• Published: England BioMed Central 11-01-2023; BMC
• Subjects: Cardiac arrest; Corticosteroids; Glucocorticoids - therapeutic use; Heart Arrest - complications; Heart Arrest - drug therapy; Heart Arrest - mortality; Humans; Mortality; Out-of-Hospital Cardiac Arrest - complications; Out-of-Hospital Cardiac Arrest - drug therapy; Out-of-Hospital Cardiac Arrest - mortality; Peritonitis - chemically induced; Peritonitis - prevention & control; Pneumonia, Ventilator-Associated - prevention & control; Randomized control trial; Randomized Controlled Trials as Topic; Survival with good functional outcome; Treatment Outcome; Corticosteroids; Randomized control trial; Survival with good functional outcome; Mortality; Cardiac arrest
• ISSN: 1364-8535; 1466-609X; 1364-8535
• DOI: 10.1186/s13054-022-04297-2

Post-cardiac arrest, outcomes for most patients are poor, regardless of setting. Many patients who do achieve spontaneous return of circulation require vasopressor therapy to maintain organ perfusion. There is some evidence to support the use of corticosteroids in cardiac arrest.
Assess the efficacy and safety of corticosteroids in patients following in- and out-of-hospital cardiac arrest.
We searched databases CINAHL, EMBASE, LILACS, MEDLINE, Web of Science, CENTRAL, ClinicalTrails.gov, and ICTRP. We included randomized controlled trials (RCTs) that examined the efficacy and safety of corticosteroids, as compared to placebo or usual care in patients post-cardiac arrest. We pooled estimates of effect size using random effects meta-analysis and report relative risk (RR) with 95% confidence intervals (CIs). We assessed risk of bias (ROB) for the included trials using the modified Cochrane ROB tool and rated the certainty of evidence using Grading of Recommendations Assessment, Development and Evaluation methodology.
We included 8 RCTs (n = 2213 patients). Corticosteroids administered post-cardiac arrest had an uncertain effect on mortality measured at the longest point of follow-up (RR 0.96, 95% CI 0.90-1.02, very low certainty, required information size not met using trial sequential analysis). Corticosteroids probably increase return of spontaneous circulation (ROSC) (RR 1.32, 95% CI 1.18-1.47, moderate certainty) and may increase the likelihood of survival with good functional outcome (RR 1.49, 95% CI 0.87-2.54, low certainty). Corticosteroids may decrease the risk of ventilator associated pneumonia (RR 0.76, 95% CI 0.46-1.09, low certainty), may increase renal failure (RR 1.29, 95% CI 0.84-1.99, low certainty), and have an uncertain effect on bleeding (RR 2.04, 95% CI 0.53-7.84, very low certainty) and peritonitis (RR 10.54, 95% CI 2.99-37.19, very low certainty).
In patients during or after cardiac arrest, corticosteroids have an uncertain effect on mortality but probably increase ROSC and may increase the likelihood of survival with good functional outcome at hospital discharge. Corticosteroids may decrease ventilator associated pneumonia, may increase renal failure, and have an uncertain effect on bleeding and peritonitis. However, the pooled evidence examining these outcomes was sparse and imprecision contributed to low or very low certainty of evidence.